Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 8, 2002, Pages 3867-3870

  Khosla, Sundeep ^a   John Ballard, F ^a   Conover, Cheryl A ^b  

^a MAYO CLINIC   (United States)

^b GROPEP PTY LTD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; SOMATOMEDIN B;

ANTIBODY SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL FEATURE; CONTROLLED STUDY; HEPATITIS C; HORMONE SYNTHESIS; HUMAN; HYPOGLYCEMIA; OSSIFICATION; OSTEOPOROSIS; OSTEOSCLEROSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SYNDROME;

HEPATITIS C VIRUS;

EID: 0036345441     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.8.8783     Document Type: Article

References (12)

1. Painful diffuse osteosclerosis after intravenous drug abuse
2. Idiopathic acquired diffuse osteosclerosis in a young woman
3. Doubling skeletal mass during adult life: The syndrome of diffuse osteosclerosis after intravenous drug abuse
4. Hepatitis C-associated osteosclerosis after blood transfusion
5. Hepatitis C-associated osteosclerosis: An unusual syndrome of acquired osteosclerosis in adults
6. Acquired osteosclerosis associated with intravenous drug use and hepatitis C infection
7. Hepatitis C-associated osteosclerosis: Late onset after blood transfusion in an elderly woman
8. Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis: Potential insights into increasing bone mass in adults
9. Insulin-like growth factors in health and disease
10. Post-translational processing of insulin-like growth factors
11. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated